ITTED 748407-2026published across the EU
Machine translation. The official title is Medicazioni avanzate aventi diritto.
A.s.l. Napoli 1 Centro has launched a tender for medical and lab supplies. The contract is estimated at €2,463,340 and runs for 2 years. The buyer has split the job into 10 lots that are awarded separately, so you can bid for the ones that suit your company.
Because this is an open procedure, any qualified company is welcome to submit a bid. All bid documents must be written in Italian and must arrive no later than 1 Dec 2026, 12:00.
Written from the facts of the notice. The official notice is the only binding text.
A.s.l. Napoli 1 Centro sees a completely standard level of bidding competition. Across 87 known contracts, they average 2.9 bids per tender, in line with the national average of 3.2 for this trade. Their latest award was a €931,133 contract (“Icatibant”), which went to Piramal Critical Care Italia S.p.A., chosen from 2 bids. At €2,463,340, this tender is well above the typical €715,290 for this trade nationally. If it is too large for your company alone, you can bid together with a partner.
We base these figures on the award notices we collect: every one we hold for this buyer, plus the last twelve months of awards in this trade across the country.
Do not lose this contract over a missing document. GroundedBid reads the tender documents and lists what the buyer asks of you, each line with the page it comes from.
A paid service provided by tender.zone.A.s.l. Napoli 1 CentroTED 711393-2026
A.s.l. Napoli 1 CentroTED 714835-2026
A.s.l. Napoli 1 CentroTED 681824-2026
In Oct 2026 a contract of this buyer went to Piramal Critical Care Italia S.p.A. for €931,133. Only 2 companies applied. This time yours can be one of them.
Asl Bat, AndriaTED 696173-2026
Asl Bat, AndriaTED 668162-2026
Azienda Ospedaliera Universitaria Policlinico Tor Vergata, RomaTED 680853-2026
SIMAP: This is not an official publication. The data published on www.simap.ch are authoritative. SIMAP data use is subject to its terms.